Mazdak Ganjalıkhani-Hakemi

Author

Isfahan University of Medical Sciences ORCID

Also Known As

Ganjalikhani-hakemi, Mazdak, Hakemi, Mazdak Ganjalikhani, M. G. Hakemi, M. Ganjalikhani Hakemi, M. Ganjalikhani-Hakemi, M. Ganjalikhani‐Hakemi, MAZDAK HAKEMI, Mazdak Ganjalikhani Hakemi, Mazdak G. Hakemi, Mazdak GANJALIKHANI-HAKEM

154

Publications

2.4K

Citations

H-Index

Concepts

All Affiliations

Isfahan University of Medical Sciences University of Isfahan Tehran University of Medical Sciences Academic Center for Education, Culture and Research Royan Institute

About

Mazdak Ganjalıkhani-Hakemi is an author at Isfahan University of Medical Sciences specializing in medicine, immunology, and cell biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	15	18	478
2	Allergy	2	2	82
3	Engineering	1	1	17
4	Natural Sciences	1	1	22
5	Public Health	1	1	11

Mazdak Ganjalıkhani-Hakemi

Publications

1.3K

Citations

H-Index

Page 1

	Year	Citations
miR-141 and miR-200a, Revelation of New Possible Players in Modulation of Th17/Treg Differentiation and Pathogenesis of Multiple Sclerosis Reza Naghavian, Kamran Ghaedi, Abbas Kiani‐Esfahani, PLoS ONE	2015	91
Signs of the presence of Th17 cells in chronic periodontal disease Mahdi Adibrad, Parviz Deyhimi, Mazdak Ganjalıkhani-Hakemi, Journal of Periodontal Research	2012	90
Therapeutic effects of extracellular vesicles from human adipose‐derived mesenchymal stem cells on chronic experimental autoimmune encephalomyelitis Morteza Jafarinia, Fereshteh Alsahebfosoul, Hossein Salehi, Journal of Cellular Physiology	2020	75
Analysis of the expression of mir-34a, mir-199a, mir-30c and mir-19a in peripheral blood CD4+T lymphocytes of relapsing-remitting multiple sclerosis patients Nooshin Ghadiri, Negaralsadat Emamnia, Mazdak Ganjalıkhani-Hakemi, Gene Clinical ImmunologyAutoimmune DiseasePeripheral Blood Cd4+tImmune Cell DevelopmentMedicine	2018	59
Cytokines (interleukin-9, IL-17, IL-22, IL-25 and IL-33) and asthma Mazdak Ganjalıkhani-Hakemi, Rahim Farahani, Roya Sherkat, Advanced Biomedical Research AsthmaInflammatory Lung DiseaseLung InflammationT-regulatory CellImmunology	2014	57
COVID-19 and the Risk of Relapse in Multiple Sclerosis Patients: A Fight with No Bystander Effect? Masoud Etemadifar, Nahad Sedaghat, Ali Aghababaee, Multiple Sclerosis and Related Disorders	2021	56
Comparison of various classifications for patients with common variable immunodeficiency (CVID) using measurement of B-cell subsets Reza Yazdani, R. Seify, Mazdak Ganjalıkhani-Hakemi, Allergologia et Immunopathologia	2016	50
Preparation and characterization of a novel nanobody against T-cell immunoglobulin and mucin-3 (TIM-3). Vida Homayouni, Mazdak Ganjalıkhani-Hakemi, Abbas Rezaei, PubMed	2016	41
Bioactive peptides: an alternative therapeutic approach for cancer management Nooshin Ghadiri, Moslem Javidan, Shima Sheikhi, Frontiers in Immunology	2024	40
Determination of HLA-B27 subtypes in Iranian patients with ankylosing spondylitis. Mohammad Hossein Nicknam, Mahdi Mahmoudi, Ali Akbar Amirzargar, PubMed HistocompatibilityImmunologyPathologyImmune-related Gene PolymorphismOrthopaedic Surgery	2008	39

Page 1